Samalin Investment Counsel, LLC Chroma Dex Corp. Transaction History

Samalin Investment Counsel, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.59 - $2.7 $159 - $270	-100 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.02 - $3.92 $202 - $392	-100 Reduced 50.0%	100 $246,000
Q2 2021 Aug 12, 2021	BUY	$6.66 - $10.92 $1,332 - $2,184	200 New	200 $1,000
Q1 2021 May 11, 2021	SELL	$4.59 - $18.74 $918 - $3,747	-200 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$4.01 - $5.56 $802 - $1,112	200 New	200 $0

17.2M

66.7K

8.2K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $375M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

Stay updated on Samalin Investment Counsel, LLC with notifications on news.